Business Standard

P&G Health Q2 results: Net profit dips 6% to Rs 72 cr, income at Rs 315 cr

The company had reported a Profit After Tax (PAT) of Rs 77 crore in the October-December period of the last fiscal

p&g, Procter & Gamble, tide

The company said its board has declared an interim dividend of Rs 200 per share for the financial year 2023-24

Press Trust of India New Delhi

Listen to This Article

Procter & Gamble Health Ltd on Tuesday said its profit after tax declined 6 per cent to Rs 72 crore for the second quarter ended December 2023.
The company had reported a Profit After Tax (PAT) of Rs 77 crore in the October-December period of the last fiscal.
Total income for the period under review stood at Rs 315 crore as against Rs 314 crore in the year-ago period, Procter & Gamble Health said in a regulatory filing.
The company follows a July-June financial year.
"This has been a challenging quarter for the company on account of an overall slowdown in the vitamins, minerals and supplements category coupled with a delayed seasonal onset," P&G Health India MD Milind Thatte said.
With improved productivity, efficiency and continued strategic investments, the company has been able to deliver a modest topline and bottomline, he added.
The company said its board has declared an interim dividend of Rs 200 per share for the financial year 2023-24.
Shares of the company settled 3.7 per cent higher at Rs 5,328.50 apiece on the BSE.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: Feb 06 2024 | 10:29 PM IST

Explore News